Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosapride Citrate Injection for Postoperative Gastrointestinal Dysfunction
NCT06782594Phase 2Recruiting
- Sponsor
- Shandong New Time Pharmaceutical
- Start
- Oct 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosapride in Postoperative gastrointestinal dysfunction (POGD), sponsored by Shandong New Time Pharmaceutical. Started Oct 2024; status: recruiting.
02
Drugs
mosapride
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on NCT06782594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06782594.